Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will own 49 percent of interest. The new firm will be named Amgen-Beta Pharmaceuticals and will help... Read more
Singapore: Malaysia-based Pharmaniaga has entered into a collaboration with Saudi Arabia-based Modern Healthcare Solutions... Read more
Singapore: US-based Actavis entered into a definitive agreement to acquire Dublin-based Warner Chilcott in a stock-for-stock... Read more
With an aim to become the number 1 hotspot for global bioscience industry in Asia, Singapore has committed $13.05 billion (S$16.1 billion)... Read more
New Delhi: Ranbaxy Laboratories has reached a final settlement agreement regarding a previously disclosed investigation by the US Department... Read more
Malaysia is now emerging as a manufacturing hub for international pharmaceutical companies and provides them smooth passage to set up manufacturing... Read more
Leveraging on the back of increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural... Read more
The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th... Read more
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government... Read more
Singapore: The US Food and Drug Administration (FDA) has approved Arbor Pharmaceutical's New Drug Application (NDA) for Nymalize (nimodipine)... Read more
Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence... Read more
Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of... Read more
Survey Box